Target intelligence / Profile preview

O-antigen of Escherichia coli serotype O2 (null)

Target
null
Molecular classification
Other (Bacterial carbohydrate surface antigen), Bacterial polysaccharide antigen, Cell surface molecule, Component of lipopolysaccharide (LPS)
01

Overview

The O-antigen of Escherichia coli serotype O2 is a strain-specific polysaccharide component of the outer membrane lipopolysaccharide (LPS) layer. It consists of repeating units of various sugar residues (in O2, mainly three L-rhamnose, N-acetylglucosamine, and N-acetyl-D-galactosamine), synthesized by a dedicated gene cluster (O-antigen gene cluster, or O-AGC)[3]. The O-antigen is highly variable among E. coli serogroups and is a key determinant for bacterial serotyping, immune evasion, and pathogenicity. It is a useful marker for strain differentiation, epidemiological studies, and is considered a potential target for diagnostic tools, monoclonal antibody therapies, and vaccine development, although major clinical products are not yet standard. In O2 strains, the O-antigen structure and biosynthetic genes may vary due to genetic recombination, leading to diversity and occasional cross-reactivity with other O-serogroups[1][3][4].

Other names
E. coli O2 O-antigenE. coli serogroup O2 O-polysaccharideO2 O-antigenO2 LPS O-antigen
02

Mechanism of action

Antibody-mediated neutralization: Antibodies bind the O-antigen, promoting complement activation, opsonophagocytosis, or blocking attachment to host cells. Inhibition of bacterial survival: Prevents bacterial evasion of host immune system. Vaccine-induced immune memory (if used as a vaccine antigen).

03

Biological functions

Immune evasion (helps bacteria avoid host immune recognition)Serotype determinant (basis for E. coli O2 classification and serotyping)Structural component of outer membrane (part of LPS)Interaction with bacteriophages and host surfaces
04

Disease associations

Infection (implicated in pathogenicity of extraintestinal pathogenic E. coli—ExPEC—and other strains)Immune evasionOther (diagnostic marker for epidemiology of E. coli infections)
05

Safety considerations

High antigenic diversity: Makes vaccine design challenging because of immune escape by structural variationPotential for cross-reactions: Antibody responses or diagnostic assays can show cross-reactivity with related serogroups (e.g., O1, O50, O53)LPS toxicity: Although O-antigen itself is not toxic, it is part of LPS, which contains lipid A (responsible for endotoxic shock if systemically targeted)Emergence of recombinant strains and antigenic variation may reduce effectiveness of both diagnostics and any developed vaccines
06

Interacting drugs

Experimental monoclonal antibodies (for diagnostics or vaccine research)

1 more in the full profile.

07

Biomarkers

O-antigen gene cluster loci (*wzx*, *wzy*, and others in the O-AGC) detected by PCR for serotyping and epidemiological surveillancePresence of specific LPS (immunoassays for E. coli O2)No standard predictive/prognostic biomarkers for treatment, but O-antigen sequence is used for diagnosis.

Beyond the preview

Go deeper on O-antigen of Escherichia coli serotype O2 (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on O-antigen of Escherichia coli serotype O2 (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call